Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
Neelima Vidula, Christina Yau, Hope S. Rugo
Topics & Concepts
Breast cancerMedicinePD-L1OncologyCancerTriple-negative breast cancerInternal medicineHazard ratioTumor-infiltrating lymphocytesProgrammed cell deathCancer researchImmunologyImmunotherapyApoptosisBiologyBiochemistryConfidence intervalCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisPARP inhibition in cancer therapy